Sleep disorder diagnostics
This article was originally published in The Gray Sheet
Executive Summary
CHAD Therapeutics has received 510(k) clearance to market its FloCHANNEL device for monitoring sleep disorders including obstructive sleep apnea. It plans to ship the FloCHANNEL device along with associated disposables by September as the first product in its new Dormio Tech division